The importance of CONUT and FA scores in predicting outcomes in patients undergoing ovarian cancer surgery
Not Applicable
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2024/08/072149
- Lead Sponsor
- All India Institue of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed or suspected epithelial cancer
Undergoing primary or interval cytoreductive surgery
willing to sign written informed consent
Exclusion Criteria
Severe infection, hematological disease, autoimmune disease and other malignant tumours
liver cancer, liver cirrhosis, hepatitis or other liver illness
any history of venous thromboembolism or coagulopathies
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete cytoreduction rates and post operative complicationsTimepoint: Baseline, 4 weeks
- Secondary Outcome Measures
Name Time Method Optimal cut-off value for CONUT & FA scores <br/ ><br>Clinicopathological characteristics <br/ ><br>Recurrence free survivalTimepoint: Baseline